Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2024 financial results and provide 2025 guidance on Wednesday, February 19th, before the market opens. A conference call has been scheduled to discuss this …

… Breakdown The standing of Charles River among financial experts … date on Charles River analyst ratings. About Charles River Charles River Laboratories was … #39;s top-line earnings. As compared to competitors … key metrics such as earnings, revenue, and growth …

… of this potential suspension for Charles River Laboratories, noting that non- … the company's earnings may be mitigated to some … there are no offsets, earnings per share could be affected … (PT) of $195 for Charles River Laboratories' stock. Investors …

Charles River Laboratories International Inc CRL reported third-quarter 2024 revenue of $1.01 billion on Wednesday, a decrease of 1.6% year over year, beating the consensus of $976.02 million. The impact of foreign currency translation benefited reported …

… ' major life science companies, Charles River Laboratories Inc., has revealed new … , Charles River Labs CEO James Foster said during the Nov. 6 earnings call … challenges that biotech companies, including Charles River Labs, are facing include a …

Charles River Laboratories International Inc. shared new … initiatives in its third-quarter earnings on Wednesday, saying the efforts … undergoing their own financial challenges. Charles River Labs provides products and services …

… 2024. Revenue and non-GAAP earnings per share guidance have been … 's third quarter. Earnings per share on a non … a year ago. Shares of Charles River are up 15% in pre … on Wednesday. For more earnings news, earnings calendar, and earnings for stocks, visit …

… currently expected by Charles River, and Charles River assumes no obligation … required by law. About Charles River Charles River provides essential products and … CHARLES RIVER LABORATORIES INTERNATIONAL, INC.   SCHEDULE 5 RECONCILIATION OF GAAP EARNINGS …

The Wilmington-based contract research organization offered new details in its third-quarter earnings about its previously-announced restructuring plans, including the extent of layoffs and site consolidations and closings thus far.